Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.54
-0.6200-0.36%
Post-market: 170.610.0700+0.04%19:59 EDT
Volume:7.32M
Turnover:1.25B
Market Cap:43.88B
PE:-12.00
High:170.98
Open:170.25
Low:169.20
Close:171.16
52wk High:176.60
52wk Low:133.73
Shares:257.32M
Float Shares:257.32M
Volume Ratio:1.26
T/O Rate:2.84%
Dividend:2.53
Dividend Rate:1.49%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.28
PE(LYR):-12.00

Loading ...

RBC Capital Keeps Their Hold Rating on NorthWest Healthcare Properties REIT (NWHUF)

TIPRANKS
·
Aug 22

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Aug 22

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Aug 22

Health Care up as Moderna Leads Biotech Higher - Health Care Roundup

Dow Jones
·
Aug 22

Soon You Can Buy Medicare Advantage Plans at Costco. What You Need to Know.

Dow Jones
·
Aug 22

HCA Healthcare Inc. Stock Rallies 5.6%, Outperforms Peers

Dow Jones
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Aug 22

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Aug 22

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Aug 22

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

TIPRANKS
·
Aug 22

Three Scientists Beat J&J's Defamation Suit over Talc Research

Reuters
·
Aug 22